Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Innovent Reports Positive Data from Phase III Trial of Tyvyt for NSCLC

CStone Reports Positive Results from Phase III Lung Cancer Trial of Immunotherapy

NeuPharma Starts Phase II Trial of Novel Treatment for Glioblastoma Multiforme

Fosun Doses 72 Subjects in China Trial of mRNA COVID-19 Vaccine

Zai Lab Granted China Priority Review for GIST Treatment

Upcoming event
August 25-27, 2020
China Standard Time
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China